World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
80
Citations
23956
World Ranking
17093
National Ranking
8562

Overview

Larry K. Kvols is affiliated with the University of South Florida in the United States. Their academic career is primarily connected with this institution.

There are no recent papers, coauthors, publication venues, book publications, fields of study, subfields, or main research topics listed for Larry K. Kvols in the available source data.

No awards or recognitions have been recorded for Larry K. Kvols.

No indication of the scientist being deceased is present, so current tense is applied throughout.

Best Publications

  • Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue.

    Larry K. Kvols;Charles G. Moertel;Michael J. O'Connell;Allan J. Schutt

  • Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms

    Charles G. Moertel;Larry K. Kvols;Michael J. O'Connell;Joseph Rubin

  • First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas.

    Jonathan R. Strosberg;Robert L. Fine;Junsung Choi;Aejaz Nasir

  • Daily Oral Everolimus Activity in Patients with Metastatic Pancreatic Neuroendocrine Tumors after Failure of Cytotoxic Chemotherapy: A Phase II Trial

    James C. Yao;Catherine Lombard-Bohas;Eric Baudin;Larry K. Kvols

  • Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system

    Kjell Öberg;L. Kvols;M. Caplin;G. Dell Fave

  • Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients

    P A Pellikka;A J Tajik;B K Khandheria;J B Seward

  • Hepatic resection for metastatic neuroendocrine carcinomas

    Florencia G. Que;David M. Nagorney;Kenneth P. Batts;Laurie J. Linz

  • Overview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin Analogs

    Dik J Kwekkeboom;Jan Mueller-Brand;Giovanni Paganelli;Lowell B Anthony

  • Somatostatin receptor-targeted radionuclide therapy of tumors: Preclinical and clinical findings

    Marion de Jong;Roelf Valkema;Francois Jamar;Larry K. Kvols

  • Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer.

    James N. Ingle;David L. Ahmann;Stephanie J. Green;John H. Edmonson

  • Detection of Somatostatin Receptors in Surgical and Percutaneous Needle Biopsy Samples of Carcinoids and Islet Cell Carcinomas

    J C Reubi;L K Kvols;B Waser;D M Nagorney

  • Long-term follow-up of renal function after peptide receptor radiation therapy with (90)Y-DOTA(0),Tyr(3)-octreotide and (177)Lu-DOTA(0), Tyr(3)-octreotate.

    Roelf Valkema;Stanislas A Pauwels;Larry K Kvols;Dik J Kwekkeboom

  • Survival and response after peptide receptor radionuclide therapy with [90Y -DOTA0,Tyr3]octreotide in patients with advanced gastroenteropancreatic neuroendocrine tumors

    Roelf Valkema;Stanislas Stanislas Pauwels;Larry Kvols;Raffaella Barone

  • The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (High-Grade) extrapulmonary neuroendocrine carcinomas

    Jonathan R. Strosberg;Domenico Coppola;David S. Klimstra;Alexandria T. Phan

  • The management of patients with advanced carcinoid tumors and islet cell carcinomas

    Charles G. Moertel;C. Michael Johnson;Michael A. McKusick;J. Kirk Martin

  • NCCN Clinical Practice Guidelines in Oncology: neuroendocrine tumors.

    Clark Oh;Benson Ab rd;Berlin Jd;Choti Ma

  • Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship.

    Raffaella Barone;Françoise Borson-Chazot;Roelf Valkema;Stephan Walrand

  • THE GLUCAGONOMA SYNDROME : CLINICAL AND PATHOLOGIC FEATURES IN 21 PATIENTS

    Robert A. Wermers;Vahab Fatourechi;Alan G. Wynne;Larry K. Kvols

  • 86Y-DOTA0-d-Phe1-Tyr3-octreotide (SMT487)—a phase 1 clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusion

    François Jamar;Raffaella Barone;Isabelle Mathieu;Stéphan Walrand

  • Distribution of somatostatin receptors in normal and tumor tissue.

    J.C. Reubi;L. Kvols;L. Kvols;E. Krenning;E. Krenning;S.W.J. Lamberts;S.W.J. Lamberts

Frequent Co-Authors

Joseph Rubin
Joseph Rubin Mayo Clinic
Eric P. Krenning
Eric P. Krenning Erasmus University Rotterdam
James N. Ingle
James N. Ingle Mayo Clinic
Domenico Coppola
Domenico Coppola Moffitt Cancer Center
Jean Claude Reubi
Jean Claude Reubi University of Bern
Dik J. Kwekkeboom
Dik J. Kwekkeboom Erasmus University Rotterdam
Bertram Wiedenmann
Bertram Wiedenmann Charité - University Medicine Berlin
Kjell Öberg
Kjell Öberg Uppsala University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative online pathways can help you jumpstart or advance your career in healthcare—even if you’re just starting out, or already enrolled in a Medicine program. For nursing professionals, choosing online dnp programs without dissertation can make pursuing a Doctor of Nursing Practice more accessible, speeding up your academic journey while reducing your workload.

If you’re eager to enter the healthcare workforce quickly, a 9 month lpn program offers a fast-track option, helping you become a Licensed Practical Nurse in less than a year. For those interested in mental health specialties, online pmhnp programs provide flexible and accredited routes toward becoming a Psychiatric Mental Health Nurse Practitioner.

Interested in the business side of healthcare? Pursuing the cheapest mha programs online can equip you with critical skills in health administration without breaking the bank. These diverse options support various goals and align with the evolving needs of healthcare careers in the USA.

Best Scientists Citing Larry K. Kvols

Trending Scientists

Recently Published Articles